Affiliation:
1. MARE—Marine and Environmental Sciences Centre/ARNET—Aquatic Research Network, ESTM, Politécnico de Leiria, 2520-614 Peniche, Portugal
2. Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
Abstract
Sphaerococcenol A is a cytotoxic bromoditerpene biosynthesized by the red alga Sphaerococcus coronopifolius. A series of its analogues (1–6) was designed and semi-synthesized using thiol-Michael additions and enone reduction, and the structures of these analogues were characterized by spectroscopic methods. Cytotoxic analyses (1–100 µM; 24 h) were accomplished on A549, DU-145, and MCF-7 cells. The six novel sphaerococcenol A analogues displayed an IC50 range between 14.31 and 70.11 µM on A549, DU-145, and MCF-7 malignant cells. Compound 1, resulting from the chemical addition of 4-methoxybenzenethiol, exhibited the smallest IC50 values on the A549 (18.70 µM) and DU-145 (15.82 µM) cell lines, and compound 3, resulting from the chemical addition of propanethiol, exhibited the smallest IC50 value (14.31 µM) on MCF-7 cells. The highest IC50 values were exhibited by compound 4, suggesting that the chemical addition of benzylthiol led to a loss of cytotoxic activity. The remaining chemical modifications were not able to potentiate the cytotoxicity of the original compounds. Regarding A549 cell viability, analogue 1 exhibited a marked effect on mitochondrial function, which was accompanied by an increase in ROS levels, Caspase-3 activation, and DNA fragmentation and condensation. This study opens new avenues for research by exploring sphaerococcenol A as a scaffold for the synthesis of novel bioactive molecules.
Funder
Fundação para a Ciência e Tecnologia
European Union’s Horizon 2020 research and innovation programme
FEDER
BEAP-MAR
Reference36 articles.
1. Global Cancer Statistics 2020: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA A Cancer J. Clin.,2021
2. Planning for tomorrow: Global cancer incidence and the role of prevention 2020–2070;Soerjomataram;Nat. Rev. Clin. Oncol.,2021
3. Recent Advancement of Bio-Inspired Nanoparticles in Cancer Theragnostic;Tripathi;J. Nanotheranostics,2023
4. New approaches and procedures for cancer treatment: Current perspectives;Debela;SAGE Open Med.,2021
5. Singh, V., Khurana, A., Navik, U., Allawadhi, P., Bharani, K.K., and Weiskirchen, R. (2022). Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics. Sci, 4.